Daily Stock List
TSS, Inc. (TSSI)
Marketbeat, RedChip, and Wall Street Resources reported earlier on TSS, Inc. (TSSI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2004, TSS, Inc. is a data center and mission critical facilities and technology services enterprise. The Company is a single source provider of mission-critical planning, design, system integration, deployment, maintenance, and development of data centers facilities and information infrastructure. The Company formerly went by the name Fortress International Group, Inc. It changed its name to TSS, Inc. in June 2013. TSS is based in Round Rock Texas.
TSS is an innovator in the hyper-dynamic mission-critical facilities industry. It provides a single-source solution for mission-critical facilities. It specializes in customizable end-to-end solutions powered by industry experts and creative services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.
The Company integrates a facility’s electrical, mechanical, security, and building envelope into a unified strategic asset. TSS’s aim is to provide its clients with the most advanced and reliable mission-enabling solutions. Its expertise is in Information Technology (IT) and also integrated facilities services.
TSS has worked across several industries. It has planned, designed, built, and maintained specialized facilities. These include data centers, communications rooms, SCIFs, call centers, laboratories, trading floors, network operations centers, and medical facilities.
TSS is an innovator and leader in mission-critical infrastructure design and support services. This includes Modular Data Centers, Assessments & Audits, Design & Budgeting, Project & Construction Services, Operations & Maintenance, and Planning & Analysis or Transformation Services. Its Data Center Services include Modular Data Centers; Data Center Health Check; Facility Assessment; Owners Representation; Strategic Options Analysis; CFD Assessment; Data Center Transition Planning; IT Equipment Relocation Services; and Arc Flash-Hazard Analysis.
This past August, TSS reported results for its Q2 ended June 30, 2016. Selected financial highlights include Q2 2016 Revenue of $7.0 million versus $5.8 million in Q2 of 2015 and $7.7 million in Q1 of 2016. The Company had a Gross Margin of 31 percent in Q2 of 2016 versus 25 percent in Q2 of 2015 and 17 percent in Q1 of 2016. TSS had an Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) profit of $197,000 versus an Adjusted EBITDA loss of $827,000 in Q2 of 2015.
TSS, Inc. (TSSI), closed Tuesday's trading session at $0.09, up 28.57%, on 145 volume with 1 trade. The average volume for the last 60 days is 6,575 and the stock's 52-week low/high is $0.02/$0.23.
Provectus Biopharmaceuticals, Inc. (PVCT)
Stock News Now, Seeking Alpha, TopPennyStockMovers, StreetInsider, The Street, TopStockAnalysts, StreetAuthorityDaily, TheMicrocapNews, Streetwise Reports, and AllPennyStocks reported earlier on Provectus Biopharmaceuticals, Inc. (PVCT), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Based in Knoxville, Tennessee, Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology biopharmaceutical company. It is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. The Company’s investigational oncology drug is PV-10. Provectus Biopharmaceuticals lists on the NYSE Mkt.
The Company’s PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. Provectus has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications.
Its PH-10 is a topical investigational drug for dermatology. PH-10 is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus Pharmaceuticals has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.
PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It is administered via direct injection into solid tumor cancers, such as melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work; and there is no known resistance. The intention of PV-10 is to kill only diseased cells upon injection into tumors. Proper cell death would be the subsequent upstream trigger for a systemic anti-tumor response.
The injection of Rose Bengal results in necrosis of tumor cells and the release of High Mobility Group Box 1 (HMGB1), with increased dendritic cell infiltration into draining lymph nodes and the activation of tumor-specific T cells. Rose Bengal is best classified
as a small molecule, though a very heavy one.
Regarding Provectus Pharmaceuticals’ PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.
Provectus Biopharmaceuticals will host its 2016 Q3 business update conference call on Monday, November 14, 2016 at 4 p.m. Eastern Standard Time. The Company will provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.
Provectus Biopharmaceuticals, Inc. (PVCT), closed Tuesday's trading session at $0.0645, down 5.01%, on 1,778,851 volume with 111 trades. The average volume for the last 60 days is 362,722 and the stock's 52-week low/high is $0.022/$0.5379.
U-Vend, Inc. (UVND)
ProTrader, Stock Commander, StockRockandRoll, PennyStockLocks, MicroCapDaily, OTCMagic, and Winston Small Cap reported recently on U-Vend, Inc. (UVND), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 2009, U-Vend, Inc. is a consumer products and automated retailing company. It creates, markets, and sells unique ice cream and related food products that are distributed to retail markets using different next-generation self-serve electronic kiosks throughout North America. U-Vend owns and operates kiosks. Essentially, the Company develops, distributes, and markets next-generation self-serve electronic kiosks and merchandisers with a digital advertising component. U-Vend has partnered with many national consumer product companies to deliver new and innovative customer retail experiences in automated frictionless settings.
U-Vend lists on the OTC Markets Group’s OTCQB. The Company has its headquarters in Santa Monica, California. U-Vend USA LLC established in April of 2010.
U-Vend has four market segments: Environmental, Retail, Service, and Mall/Airport Islands. U-Vend’s focus is Environmental and Retail. It has designed a Mall and Airport Multipurpose Island. U-Vend took many of its Self-Serve kiosks and bundled them into an "island", all in one central location. This has created a destination concept within a mall and/or airport setting. The island is always associated with a co-branding anchor as part of the complete concept.
U-Vend’s customer base comprises retail installations, co-branding partnerships, direct sales, and the general population desiring to own their own business. U-Vend end-users include national chains, independent owner operators, big box stores, restaurants, malls, airports, casinos, universities, and colleges, among others. U-Vend offers low-cost investment with high return potential.
The design of all U-Vend kiosks have been to be especially technology-savvy. In some cases kiosks are wireless, managed on line 24/7, and accept credit and debit cards. In Retail kiosks, a touch screen catalogue is provided for customers to scroll through and review all products being provided in the kiosk.
Recently, U-Vend announced that Mr. Michael W. Crone joined the Company as Senior Vice President. Mr. Crone is a proven industry professional with more than four decades of consumer sales, marketing and strategic planning experience. He will report to Mr. Mark Chapman, President of U-Vend, America, Inc.
This month, U-Vend announced that its new "Grab It-Taste It-Love It" Mini Melts ice cream merchandiser program is achieving considerable demand in the first few months of its launch. This program is specifically targeted for smaller consumer retail locations.
The targeting of the program is at high-traffic establishments. This includes convenience stores, fast food locations and gas stations that are not large enough to support the placement of a large vending machine, but will support the addition of a lower cost, high-margin product sales solution such as the U-Vend merchandiser. U-Vend’s merchandiser freezer comes in 5.2 cubic ft. and 3.5 cubic ft. sizes and holds between 100-200 units of pre-cup Mini Melts ice cream.
U-Vend, Inc. (UVND), closed Tuesday's trading session at $0.05, up 11.11%, on 19,300 volume with 9 trades. The average volume for the last 60 days is 73,934 and the stock's 52-week low/high is $0.03/$0.185.
NEMUS Bioscience, Inc. (NMUS)
We are highlighting NEMUS Bioscience, Inc. (NMUS) today, here at the QualityStocks Daily Newsletter.
NEMUS Bioscience, Inc. is a biopharmaceutical company focusing on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in international markets. A highly qualified team of executives with decades of biopharmaceutical experience and significant background in early-stage drug development leads the Company. NEMUS Bioscience is based in Costa Mesa, California and the Company’s shares trade on the OTC Markets Group’s OTCQB.
NEMUS’ vision is to provide physicians and patients the medical benefits of "condition-specific" cannabinoids to alleviate symptoms associated with a continuum of diseases. The Company is concentrating on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds - cannabinoids - designed to alleviate a variety of diseases and symptoms through selectively targeting CB1 and CB2 receptors.
NEMUS Bioscience signed a research agreement with the University of Mississippi (UM) in 2015. The research agreement is to study and conduct R&D on cannabidiol (CBD) containing formulations. NEMUS is building a proprietary product pipeline focusing on the range from extraction processes to molecular design and unique methods of cannabinoid drug delivery to address medical needs in the multi-billion-dollar worldwide market opportunities.
NEMUS, employing certain proprietary technology licensed from the University of Mississippi (UM), is working to develop novel ways to deliver cannabinoid-based drugs for specific indications. Its objective is optimizing the clinical effects of such drugs, while limiting the potential adverse events. The Company’s strategy will explore the use of natural and synthetic compounds, alone or in combination.
NEMUS Bioscience has completed the validation stage of testing of its cannabinoid-based therapy undergoing development for the treatment and management of glaucoma. The therapy, NB1111, is a proprietary prodrug version of tetrahydrocannabinol (THC) that has been shown to reduce intraocular pressure (IOP) in a rabbit glaucoma model. This compound has been in-licensed from NEMUS’ commercial and research partner, the University of Mississippi (UM).
NEMUS Bioscience announced this past June that data earlier obtained from UM showed that in a rabbit normal ocular pressure model that examined the effects of NB1111, the proprietary NEMUS prodrug of tetrahydrocannabinol (THC), NB1111 provided superior tissue penetration and concentration. This is whether administered in a solid lipid nanoparticle (SLN) or in an eyedrop emulsion, in comparison to standard THC in the same eyedrop vehicles.
NEMUS Bioscience earlier announced, in conjunction with UM, the identification of a unique cannabidiol (CBD) derivative possessing analgesic properties. It will be advanced by way of Investigational New Drug (IND)-enabling studies for the treatment of pain disorders, particularly those related to neuropathy.
NEMUS Bioscience has signed a Letter of Intent (LOI) with Teewinot Life Sciences Corp. Teewinot is an international leader in the use of synthetic biology to create pharmaceutical grade cannabinoids. The expectation is that the LOI will lead to the signing of a license agreement in which NEMUS Bioscience would license biosynthetically-derived cannabinoid molecules founded on NEMUS' proprietary prodrug technology.
NEMUS Bioscience, Inc. (NMUS), closed Tuesday's trading session at $1.39, up 41.69%, on 340,746 volume with 524 trades. The average volume for the last 60 days is 8,568 and the stock's 52-week low/high is $0.37/$1.00.
Accelera Innovations, Inc. (ACNV)
FinestPennyStocks reported previously on Accelera Innovations, Inc. (ACNV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Accelera Innovations, Inc. is a healthcare service company listed on the OTCQB. Its focus is healthcare technology, and its emphasis is the development of Internet-based software in the U.S. Accelera has its Accelera Technology, which is an Internet-based software platform that enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. Accelera Innovations specializes in interfacing healthcare data technologies to transmit directly into the healthcare information exchange.
The Company is based in Frankfort, Illinois, and it has its wholly-owned subsidiary, Advance Life, Inc. Essentially, Accelera Innovations is a collaboration of companies designed to improve the outcomes of post-acute and long term care patients. Its mission is to improve patient outcomes and lower costs, through educating providers, leveraging its technology and changing the model of payment to a value-based system.
Accelera Innovations will first focus on its technology assets that were licensed to it by its majority shareholder, Synergistic (a privately-held company organized under the laws of Illinois). Accelera Innovations was granted a 30-year exclusive, non-transferrable global license for the Accelera Technology.
The Accelera Technology is a proprietary Internet-based, software platform fully functional in its current state. The design of this platform is to provide interoperable technology intended to improve the quality of care while lessening costs.
In addition, Accelera Innovations provides care services. This includes pediatrics, geriatrics, as well as critical care. It also provides billing, practice management, and administrative services to doctors and other clinicians; as well as in-house psychiatric evaluations, neuropsychological testing, assessments and treatment services, counseling, and medication management services.
Furthermore, Accelera provides laboratory services consisting of EKG, drug screens, blood work ups, and sleep lab evaluation services. The Company also provides detoxification services that consist of alcohol and various drugs and substances with directorship to methadone maintenance programs; military entrance processing station screenings; and research trials as a contracted site for different pharmaceutical entities. Accelera also engages in the acquisition and operation of home health businesses.
Accelera is aggressively marketing its home health care services. Its Management sees a growing demand of medical professionals looking for information and then using the Advance Life subsidiary’s effective and efficient home health care services. Advance Life has positioned itself to provide home health care and increase its business, fulfilling the needs of this market segment.
Regarding Accelera HIS (Hospital Information System), this solution automates the operation of individual departments and their respective functions within the inpatient environment. These hospital-based transaction and decision support systems form the heart of systems, which, in combination with other tools designed to directly support clinical decision making, help streamline the care process over the range of care.
Accelera Innovations, Inc. (ACNV), closed Tuesday's trading session at $0.007616, up 8.80%, on 5,597,507 volume with 111 trades. The average volume for the last 60 days is 2,769,249 and the stock's 52-week low/high is $0.0025/$0.042.
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.94, up 7.43%, on 22,224 volume with 21 trades. The stock’s average daily volume over the past 60 days is 4,884, and its 52-week low/high is $0.6882/$1.06.
OurPet's Company today reports record third-quarter revenue of $7.26 million, an increase of 21% compared to revenues of $5.99 million reported in the same period of 2015. Net income for the third quarter ended September 30, 2016, increased 21% to $495,669, or $0.025 per share, compared to $410,450, or $0.020 per share, for the same period of 2015. Third quarter 2015 results included a one-time U.S. Custom exam refund of $94,000. Discounting the $94,000 refund, the adjusted net income between third quarters 2015 and 2016 grew 57%.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
OurPet’s Company Reports Record Third Quarter 2016 Results
OurPet's Company CFO to Present at the MicroCap Conference in Philadelphia
Kathleen Homyock of OurPet's Company Presents Smart Technology Trends to Canadian Pet Industry
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $5.05, up 0.80%, on 17,067 volume with 25 trades. The stock’s average daily volume over the past 60 days is 33,916, and its 52-week low/high is $0.51/$5.84.
eXp World Holdings Inc. announced today that Darren James, principal of the Baton Rouge brokerage Darren James Real Estate Experts has transitioned his team of agents and brokers over to eXp Realty, the Agent-Owned Cloud Brokerage®. "The eXp Realty business model is more progressive and agent-centric than any I've seen in my 15 years in this business," said James. "This is a tremendous opportunity, not just for me and for my family, but for all of the agents who have been great and loyal contributors to my success."
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
Darren James Real Estate Team Joins eXp Realty in Louisiana
Brent Gove Team Joins eXp Realty in Sacramento
Top International Luxury Agent in South Texas San Joins eXp Realty
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0021, up 50.00%, on 129,569,267 volume with 486 trades. The stock’s average daily volume over the past 60 days is 20,964,884 and its 52-week low/high is $0.001/$0.143.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Advances Its Plans for Africa
Dominovas Energy Petitions for Project Grants Through United States Trade and Development Agency
Dominovas Energy Seeks to Become an Exclusive Energy Provider for the University of Johannesburg
Net Element, Inc. (NETE)
The QualityStocks Daily Newsletter would like to spotlight Net Element, Inc. (NETE). Today, Net Element, Inc. closed trading at $1.10, up 4.76%, on 106,649 volume with 188 trades. The stock’s average daily volume over the past 60 days is 451,616, and its 52-week low/high is $0.50/$4.60.
Net Element, Inc. (NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprises in the United States and select emerging markets. Leveraging a network of subsidiaries operating in the mobile payments and value-added transactional services space – including Unified Payments, Aptito and PayOnline – Net Element is committed to promoting consistent and strong growth, as illustrated by its position as one of the South Florida Business Journal's 'Top 25 Fastest-Growing Technology Companies'. In the first seven months of 2016 alone, the company realized a 77 percent year-over-year increase in transactional processing volume when discounting the effects of foreign currency exchange.
A major contributor to this sustained growth has been Net Element's PayOnline subsidiary, which offers state-of-the-art payment technologies that are currently employed by more than 3,000 online enterprises across Europe and Asia. To bolster this position, the company has continued to expand its presence in Central Asia, most recently through the opening of a new office in Kazakhstan, the largest country in the region. Since its first anchor project in Kazakhstan in June 2015, PayOnline has entered agreements with more than 180 online merchants in Central Asia, and the region is expected to offer an opportunity for tremendous growth in the coming years as the proliferation of electronic commerce takes hold.
The growth of PayOnline throughout Eurasia has been accompanied by both awards and industry recognition. Independent analytical agency Markswebb Rank & Report ranked PayOnline as a top five payment acceptance company in its 2016 Internet Acquiring Rank report, and a second analytical agency, Tagline.ru, ranked PayOnline as a leading payment gateway in its 2016 Payment Systems Rating. The company's management team attributes this success to PayOnline's "innovative, customer-focused products and services."
Net Element is led by a seasoned management team offering a unique blend of leadership, vision, experience and creative energy. Oleg Firer, the company's chief executive officer, formerly served as the executive chairman of Unified Payments up until its acquisition by Net Element's TOT Group in April 2013. Under his guidance, Unified Payments achieved rapid growth, earning the top spot on Inc. Magazine's list of fastest-growing companies in 2012. As a result, Firer was recognized by Forbes as one of the 'Five Incredible Entrepreneurs' and by Business Leader Magazine as a 'Top Entrepreneur in South Florida'. Disclaimer
Net Element, Inc. Company Blog
Net Element, Inc. News:
ExLine Becomes a Client of Net Element's PayOnline in Kazakhstan
Dunkin' Donuts Becomes a Client of Net Element's PayOnline in Russia
Net Element Announces Growth in Transaction Processing Volume
Agora Holdings, Inc. (AGHI)
The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.17, up 3.03%, on 255,703 volume with 54 trades. The stock’s average daily volume over the past 60 days is 521,652, and its 52-week low/high is $0.01/$0.50.
Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.
Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.
For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.
Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.
Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer
Agora Holdings, Inc. Company Blog
Agora Holdings, Inc. News:
Agora Holdings, Inc. Issues Corporate Update on Current, Future Endeavors
Agora Holdings, Inc. Launches FRAME Social Media App
Agora Holdings Inc. Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
Today's Top 3
Profitable Trader Authority
Small Cap Firm
The QualityStocks Public Company Sponsor News